Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GnRH agonist before frozen embryo transfer in hyperandrogenic PCOD
IRCT20140818018842N15Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of leuprolide and estradiol valerate in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Endometrial thickness, Implantation rate and 2 more. Started May 2018; status: completed.
02
Drugs
leuprolideestradiol valerate
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20140818018842N15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140818018842N15.